As a consequence, stabilized OCT1 contributed to ALDH1A1 upregulation and enhanced cancer stemness, implying the therapeutic potential of targeting serial ubiquitination in patients with CRC [55]. The gene discussed is ALDH1A1; the disease is colorectal carcinoma.